Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

Dow Flat as Software Slide Offsets Goldman's Gains
Markets Daniel Marsh

Dow Flat as Software Slide Offsets Goldman's Gains

The Dow ended nearly flat on Wednesday as a decline in software stocks, led by Microsoft and Salesforce, countered a boost from Goldman Sachs.

GS MSFT CRM JNJ BA IBM HON SCHW WFC GOOGL TSLA META AAPL AMZN
AI Hardware Stocks Surge as Software Slumps, Widening Sector Divide
Markets Daniel Marsh

AI Hardware Stocks Surge as Software Slumps, Widening Sector Divide

US equities declined as AI hardware stocks surged on margin improvements, while software shares slumped, creating a 21-point performance gap.

SMCI DELL NOW WDAY SCHW GOOGL TSLA WFC
Advanced Biomed Surges 74.6% After Terminating $25M Equity Facility
Markets Daniel Marsh

Advanced Biomed Surges 74.6% After Terminating $25M Equity Facility

Shares of Advanced Biomed (ADVB) jumped 74.6% after the company terminated a $25 million equity facility, removing overhang of potential dilution.

ADVB XBI IWM
Bank of America Stock Nears 52-Week High, Reducing Buyback Efficiency
Markets Daniel Marsh

Bank of America Stock Nears 52-Week High, Reducing Buyback Efficiency

Bank of America shares rose 0.6% to $61.57, approaching their 52-week high, which reduces the effectiveness of buyback programs as each dollar repurchases fewer shares.

BAC JPM C WFC
NIO Stock Drops as Chip Unit GeniTech Stake Valued at $763M
Markets Daniel Marsh

NIO Stock Drops as Chip Unit GeniTech Stake Valued at $763M

NIO shares declined 2.5% after its remaining 62.7% stake in chip subsidiary GeniTech was valued at approximately $763 million, representing 7.8% of the company's market capitalization.

NIO MS XPEV LI
Arrowhead Surges 23% on Positive Plozasiran Phase 3 Data
Markets Daniel Marsh

Arrowhead Surges 23% on Positive Plozasiran Phase 3 Data

Arrowhead Pharmaceuticals (ARWR) shares surged 23% after Plozasiran Phase 3 data showed 79-81% median triglyceride reduction and 78% fewer pancreatitis events.

ARWR XBI IONS
NuScale Power Drops Below Equity Sale Price Amid Dilution Concerns
Markets Daniel Marsh

NuScale Power Drops Below Equity Sale Price Amid Dilution Concerns

NuScale Power shares slipped 1.7% to $8.56, trading below its recent equity sale average of $9.69. Dilution concerns and heavy cash burn overshadow nuclear policy gains.

SMR OKLO NNE BWXT
Transocean and Valaris Shares Rise as Merger Spread Narrows to 2.25%
Markets Daniel Marsh

Transocean and Valaris Shares Rise as Merger Spread Narrows to 2.25%

Transocean (RIG) gained 1.24% to $5.305, while Valaris (VAL) rose 1.18% to $79.00, with the merger spread narrowing to 2.25% as the companies await regulatory clearance.

RIG VAL NE SDRL USO
Coeur Mining Market Cap Ties Pan American Silver Ahead of Key Cash Flow Report
Markets Daniel Marsh

Coeur Mining Market Cap Ties Pan American Silver Ahead of Key Cash Flow Report

Coeur Mining's market cap edges past Pan American Silver as investors await Q2 results on August 5 to assess cash flow from recently acquired mines.

CDE PAAS HL GLD SLV
Dow Rises 142 Points; Two Stocks Drive Nearly 70% of Gain
Markets Daniel Marsh

Dow Rises 142 Points; Two Stocks Drive Nearly 70% of Gain

The Dow Jones Industrial Average climbed 142 points by midday Wednesday, with Caterpillar and Goldman Sachs accounting for nearly 70% of the gain.

CAT GS JNJ NVDA HON MSFT CRM AMZN CVX GOOGL TSLA
U.S. Stocks Hold Steady as Energy Surge Offsets Small-Cap Weakness
Markets Daniel Marsh

U.S. Stocks Hold Steady as Energy Surge Offsets Small-Cap Weakness

U.S. equities were little changed at midday Wednesday, with energy shares surging on higher oil prices while small caps lagged, as investors awaited earnings from Alphabet and Tesla.

GOOGL TSLA T SMCI XLE IWM SPY QQQ DIA
Mentari's $200M Private Placement Boosts InMed Merger Funding
Markets Daniel Marsh

Mentari's $200M Private Placement Boosts InMed Merger Funding

InMed Pharmaceuticals (INM) shares rose 21% after Mentari Therapeutics revealed a $200M private placement, boosting total merger financing to $490M.

INM XBI